LARRY NORRIS: Open Payments
NPI 1356343271 · OPP, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 18 payments from 8 companies in 2025. Trend: 2023 $34 · 2024 $153 · 2025 $375
Food & beverage: $356Education: $19
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $171 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Exact Sciences Corporation | 3 | $51 |
| Novo Nordisk Inc | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, TRELEGY ELLIPTA, Cologuard Collection Kit, JARDIANCE, Rybelsus, CAPLYTA, REXULTI, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
